ANGPTL2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Further studies are needed to determine whether ANGPTL2 signaling in tumor cells contributes to acquisition of resistance to ICI therapy in both tRCC and ccRCC.